Abstract
By focusing on the studies of primate behaviour and human neuroscience, we describe how different neurological processes are the base of proximate aspects of social-decision making. We also review the fact that distinct aspects of animal behaviour are not under conscious or abstract control and that instead they may be regulated by adaptive ´rules of thumb´. In particular, by describing the microbiota- gut-brain axis we elaborate on suggesting that microbiota has an influence on within-individual aspects of social decision making and in particular facilitating social interactions. Finally, we present comparative evidence of the role of microorganisms as modifiers of aspects of kinship, reproduction and group-members´ recognition, suggesting how microbiota also has an influence on betweenindividual aspects of decision making, which are themselves primary aspects of cooperation. In summary, we propose that modern socioeconomic choice theories may still benefit from alternative theoretical frameworks that consider the human being as a complex organism, with intrinsic constraints and capacities product of its evolutionary history, and not just as an exclusively-cognitive decision maker acting independently of its closest partners and commensals: its microbiota.
Keywords: Neuroeconomics, microbiota, probiotics, decision making process, social neurosciences.
Current Pharmaceutical Design
Title:Social Neuroeconomics: The Influence of Microbiota in Partner-Choice and Sociality
Volume: 20 Issue: 29
Author(s): Montiel-Castro, Augusto J., Baez-Yanez, Mario G. and Pacheco-Lopez Gustavo
Affiliation:
Keywords: Neuroeconomics, microbiota, probiotics, decision making process, social neurosciences.
Abstract: By focusing on the studies of primate behaviour and human neuroscience, we describe how different neurological processes are the base of proximate aspects of social-decision making. We also review the fact that distinct aspects of animal behaviour are not under conscious or abstract control and that instead they may be regulated by adaptive ´rules of thumb´. In particular, by describing the microbiota- gut-brain axis we elaborate on suggesting that microbiota has an influence on within-individual aspects of social decision making and in particular facilitating social interactions. Finally, we present comparative evidence of the role of microorganisms as modifiers of aspects of kinship, reproduction and group-members´ recognition, suggesting how microbiota also has an influence on betweenindividual aspects of decision making, which are themselves primary aspects of cooperation. In summary, we propose that modern socioeconomic choice theories may still benefit from alternative theoretical frameworks that consider the human being as a complex organism, with intrinsic constraints and capacities product of its evolutionary history, and not just as an exclusively-cognitive decision maker acting independently of its closest partners and commensals: its microbiota.
Export Options
About this article
Cite this article as:
Montiel-Castro , J. Augusto, Baez-Yanez , G. Mario and Gustavo Pacheco-Lopez, Social Neuroeconomics: The Influence of Microbiota in Partner-Choice and Sociality, Current Pharmaceutical Design 2014; 20 (29) . https://dx.doi.org/10.2174/1381612820666140130210631
DOI https://dx.doi.org/10.2174/1381612820666140130210631 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Modulation of the Intrinsic Properties of Motoneurons by Serotonin
Current Pharmaceutical Design Catechol-O-Methyl Transferase as a Drug Target for Schizophrenia
CNS & Neurological Disorders - Drug Targets Lifestyle and Genetic Contributions to Cognitive Decline and Hippocampal Structure and Function in Healthy Aging
Current Alzheimer Research Innovations to Control the Environment for Persons with Movement Disorders: Support in Home Care
Recent Patents on Biomedical Engineering (Discontinued) Ophthalmological and Otological Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Cognition and Emotions in Recurrent Depressive Disorders - The Role of Inflammation and the Kynurenine Pathway
Current Pharmaceutical Design Ca<sub>v</sub>1.3 Channels as Key Regulators of Neuron-Like Firings and Catecholamine Release in Chromaffin Cells
Current Molecular Pharmacology Therapeutic Potential of Cannabinoids in Schizophrenia
Recent Patents on CNS Drug Discovery (Discontinued) Cognitive Impairment and Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Endocannabinoid System in Ageing: A New Target for Drug Development
Current Drug Targets Opportunities for Photoacoustic-Guided Drug Delivery
Current Drug Targets Advances in the Discovery of Novel Positive Allosteric Modulators of the α7 Nicotinic Acetylcholine Receptor
Recent Patents on CNS Drug Discovery (Discontinued) Parietal Lobe Dysfunction in Schizophrenia: A Review
Current Psychiatry Reviews Pro-Inflammatory Gene Variants in Myocardial Infarction and Longevity: Implications for Pharmacogenomics
Current Pharmaceutical Design ApoE ε4 Allele Related Alterations in Hippocampal Connectivity in Early Alzheimer’s Disease Support Memory Performance
Current Alzheimer Research Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer’s Disease
Current Medicinal Chemistry Functional Neuroimaging in Memory and Memory Disturbances
Current Medical Imaging New Insights into the Pathogenesis of Fibromyalgia Syndrome: Important Role of Peripheral and Central Pain Mechanisms
Current Rheumatology Reviews The Therapeutic Potential and Usage Patterns of Cannabinoids in People with Spinal Cord Injuries: A Systematic Review
Current Neuropharmacology Cell Therapy for Inner Ear Diseases
Current Pharmaceutical Design